December 2025
1. FU D, Fu H, Wang Y, Yang K, et al
   Therapeutic potentials of plant?based antioxidants on colorectal cancer: Challenges and perspectives (Review).
   Int J Oncol. 2025;67:107.
   

   >> Share

   
   November 2025
2. COSTABILE V, Duraturo F, Delrio P, Rega D, et al
   [Corrigendum] Lithium chloride induces mesenchymal?to?epithelial reverting transition in primary colon cancer cell cultures.
   Int J Oncol. 2025;67:94.
   

   >> Share

   
   August 2025
3. PAN S, Deng Y, Fu J, Zhang Y, et al
   [Retracted] N6?methyladenosine upregulates miR?181d?5p in exosomes derived from cancer?associated fibroblasts to inhibit 5?FU sensitivity by targeting NCALD in colorectal cancer.
   Int J Oncol. 2025;67:62.
   

   >> Share

   
   March 2025
4. TAN S, Li S, Xia L, Jiang X, et al
   Long non?coding RNA ABHD11?AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway.
   Int J Oncol. 2025;66:20.
   

   >> Share

   
   
5. YANG Z, Chen Y, Wei X, Wu D, et al
   [Corrigendum] Upregulated NTF4 in colorectal cancer promotes tumor development via regulating autophagy.
   Int J Oncol. 2025;66:19.
   

   >> Share

   
   
6. JIN Z, Li Y, Yi H, Wang M, et al
   Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review).
   Int J Oncol. 2025;66:22.
   

   >> Share

   
   
7. LI Z, Deng L, Cheng M, Ye X, et al
   Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review).
   Int J Oncol. 2025;66:24.
   

   >> Share

   
   February 2025
8. ZHANG Y, Wang J, Quan R, Lyu L, et al
   circ_0004662 contributes to colorectal cancer progression by interacting with hnRNPM.
   Int J Oncol. 2025;66:14.
   

   >> Share

   
   January 2025
9. PATLOLLA JMR, Zhang Y, Li Q, Steele VE, et al
   [Corrigendum] Anti?carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane?induced colonic aberrant crypt foci formation in rats.
   Int J Oncol. 2025;66:3.
   

   >> Share

   
   December 2024
10. NAKANO Y, Masuda T, Sakamoto T, Tanaka N, et al
    SHARPIN is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression.
    Int J Oncol. 2024;65:113.
    

    >> Share

    
    October 2024
11. LI H, Li D, Meng N
    [Retracted] Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells.
    Int J Oncol. 2024;65:91.
    

    >> Share

    
    
12. WU K, Wu QX, Yuan SX, Wang DX, et al
    [Corrigendum] The role of IGFBP?5 in mediating the anti?proliferation effect of tetrandrine in human colon cancer cells.
    Int J Oncol. 2024;65:93.
    

    >> Share

    
    
13. TONG G, Shen Y, Li H, Qian H, et al
    NLRC4, inflammation and colorectal cancer (Review).
    Int J Oncol. 2024;65:99.
    

    >> Share

    
    September 2024
14. ZENG W, Liu H, Mao Y, Jiang S, et al
    Myeloid?derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review).
    Int J Oncol. 2024;65:85.
    

    >> Share

    
    June 2024
15. KIM BR, Kim DY, Tran NL, Kim BG, et al
    Daunorubicin induces GLI1?dependent apoptosis in colorectal cancer cell lines.
    Int J Oncol. 2024;64:66.
    

    >> Share

    
    April 2024
16. KAKAFIKA MG, Lyta AA, Gavriilidis GI, Tsiftsoglou SA, et al
    Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K?562 and colorectal HCT?116 cancer cells.
    Int J Oncol. 2024;64:42.
    

    >> Share

    
    
17. SUN J, Chen S, Zang D, Sun H, et al
    Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review).
    Int J Oncol. 2024;64:44.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share